Medical Education on High-Risk Non-Muscle Invasive Bladder Cancer

Pfizer is offering a competitive Independent Medical Education (IME) grant opportunity aimed at supporting educational initiatives that address unmet needs in the treatment of high-risk non-muscle invasive bladder cancer (HR-NMIBC), particularly in BCG-naive patients. As part of its broader mission to enhance patient outcomes in alignment with emerging clinical developments, Pfizer has released this Request for Proposals (RFP) to encourage educational projects that highlight emerging data and encourage appropriate patient selection and care coordination. The program is specifically designed to fund projects that foster awareness and understanding of new treatment pathways, complications from existing treatment paradigms, and evolving best practices in immunotherapy integration. The funding opportunity targets medical education organizations and institutions across the United States. Eligible applicants include accredited healthcare education providers such as medical, nursing, dental, and pharmacy schools; hospitals and healthcare institutions; medical societies; professional organizations; and medical education companies. Individual applicants and unaffiliated physician groups are not eligible. Collaborative proposals involving multiple institutions are allowed, provided the lead applicant organization plays a significant role in the project and can legally receive funding directly from Pfizer. The project lead must be affiliated with the applying organization either as an employee or contractor. Projects may take various formats, including online modules, downloadable materials, symposia, interactive tools, podcasts, or peer-to-peer education. The content must center on one or more of the following focus areas: emerging clinical data in HR-NMIBC and their impact on treatment strategies, identifying and selecting appropriate patients based on clinical risk stratification, and fostering shared decision-making between urology and medical oncology professionals. Proposals evaluating therapeutic or diagnostic efficacy will not be considered, as clinical research is outside the scope of this grant. The target audience includes a multidisciplinary team of healthcare providers such as urologists, medical oncologists, advanced practitioners, and nurses working in both academic and community settings. The total funding pool available under this RFP is $500,000, and individual grants may request between $50,000 and $200,000, inclusive of direct and indirect costs. Indirect costs (institutional overhead) may not exceed 28% of the total budget, per Pfizer policy. Projects may run for up to 18–24 months, with an anticipated start date of December 1, 2025. All applications must be submitted by September 17, 2025, at 11:59 PM EST. Notifications of awards are expected to be issued by October 14, 2025. The final project end date is projected as April 31, 2027. To apply, applicants must access Pfizer’s CyberGrants platform at www.cybergrants.com/pfizer/knowledge. Proposals must be submitted under the Independent Medical Education/Knowledge Gap Application type. Applicants must complete all required sections of the online form and upload a proposal file that includes the goals and objectives, needs assessment, project design, evaluation plan, dissemination plan, timeline, budget narrative, and institutional roles. For the Competitive Grant field, applicants should select "Yes," and identify the primary area of interest as "Genitourinary" and the specific program name as "2025 ONC US NMIBC Unmet Needs IME." Any technical issues with the CyberGrants platform should be directed through the “Technical Questions” link on the portal. Content-related inquiries regarding this RFP may be sent via email to Grant Officer Lori Carpenter at lori.carpenter@pfizer.com using the subject line “2025 ONC US NMIBC Unmet Needs.” Pfizer does not allow negotiation on grant agreement terms except in cases of legal conflict, and funds will only be disbursed to eligible U.S.-based legal entities. Applications not following submission guidelines will be disqualified.

Ensure the proposal file is uploaded in the correct field and all application fields are complete. Late or misformatted applications will be disqualified.